Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4362684 | 0.80 | ENPEP (0.46) | ENPEPALDH1A1ANPEPGSTK1CYP3A4 | |
| SCHEMBL3175406 | 0.71 | ALOX15 (0.42) | KMT2A | |
| SCHEMBL13176808 | 0.70 | ENPEP (0.31) | ENPEP | |
| SCHEMBL37411 | 0.70 | ENPEP (0.39) | ENPEPANPEPGSTK1MEN1FAAH | |
| SCHEMBL27972090 | 0.70 | GPR84 (0.42) | — | |
| SCHEMBL26946027 | 0.69 | PAOX (0.34) | ENPEPALDH1A1GSTK1 | |
| SCHEMBL2576303 | 0.68 | ENPEP (0.38) | ENPEPANPEPGSTK1MEN1FAAH | |
| SCHEMBL10307750 | 0.68 | GSTK1 (0.48) | ENPEPALDH1A1ANPEPGSTK1 | |
| SCHEMBL15135048 | 0.68 | FOLH1 (0.44) | ENPEPALDH1A1GSTK1 | |
| SCHEMBL3110906 | 0.68 | ALDH1A1 (0.41) | ENPEPALDH1A1GSTK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118714936-A | Methods and uses of microbial compositions, components or metabolites for the treatment of vagal nerve related diseases, disorders and conditions | 奇迹生物公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118265532-A | Methods and uses of microbiome compositions, components or metabolites for treating neurodegenerative diseases | 奇迹生物公司 | 2024-06-28 | — | — | CN | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |